Sivik Global Healthcare LLC In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 6, 2024), Sivik Global Healthcare LLC reported 33 stock positions worth $234.6 million . Its top holding was SS SPDR S&P Biotech ETF (XBI) at 12.6% of the portfolio, followed by Eli Lilly (LLY, 5.5% ) and Tenet Healthcare (THC, 4.6% ). Compared with Q2 2024, it opened 7 new positions, sold out of 11, added to 8 and reduced 13. The biggest buy was a new position in SS SPDR S&P Biotech ETF (XBI) and the biggest sale an exit from Merck (MRK).
Location GREENWICH, CT
CIK 0001596452
Portfolio Value $234.6M (Q3 2024) Holdings 33 stocks · $234.6M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q2 2024 XBI SS SPDR S&P Biotech ETF 300,000 $29.6M New LLY Eli Lilly & Co. 14,500 $12.8M Reduce -3.3% THC Tenet Healthcare Corp. 65,000 $10.8M Reduce -7.1% NVO Novo-Nordisk A/S-Spons ADR 90,000 $10.7M No change UHS Universal Health Services-B 45,000 $10.3M Add +12.5% MCK McKesson Corp. 20,000 $9.9M Add +11.1% SYK Stryker Corp. 27,000 $9.8M Add +8.0% BSX Boston Scientific Corp. 105,000 $8.8M Reduce -8.7% ISRG Intuitive Surgical Inc. 17,500 $8.6M No change DHR Danaher Corp. 30,000 $8.3M No change HCA HCA Healthcare Inc. 20,000 $8.1M Reduce -20.0% SGRY Surgery Partners Inc. 230,000 $7.4M Reduce -8.0% ACHC Acadia Healthcare Co. Inc. 115,000 $7.3M Add +43.7% ABT Abbott Laboratories 60,000 $6.8M New AVTR Avantor Inc. 250,000 $6.5M No change BDX Becton Dickinson and Co. 25,000 $6.0M No change BAX Baxter International Inc. 150,000 $5.7M Add +50.0% COR Cencora Inc. 25,000 $5.6M Reduce -3.9% MDT Medtronic PLC 60,000 $5.4M New RVTY Revvity Inc. 40,000 $5.1M New WST West Pharmaceutical Services 17,000 $5.1M Add +30.8% CAH Cardinal Health Inc. 45,000 $5.0M Reduce -25.0% SEM Select Medical Holdings Corp. 140,000 $4.9M Reduce -3.5% EHC Encompass Health Corp. 50,000 $4.8M Reduce -9.1% VRTX Vertex Pharmaceuticals Inc. 10,000 $4.7M Reduce -33.3% SNN Smith & Nephew PLC -Spon ADR 140,000 $4.4M Reduce -6.7% ZBH Zimmer Biomet Holdings Inc. 40,000 $4.3M New RGEN Repligen Corp. 25,000 $3.7M Add +66.7% MRVI Maravai Lifesciences Hldgs-A 425,000 $3.5M Reduce -5.6% HUM Humana Inc. 10,000 $3.2M Add +33.3% TEVA Teva Pharmaceutical-SP ADR 170,000 $3.1M Reduce -15.0% STVN Stevanato Group SPA 140,000 $2.8M New ASND Ascendis Pharma A/S 10,000 $1.5M New
Options reported separately and not counted above: PUT - SPY 100 @ 565 EXP 10/31/2024 puts ($861K), PUT - SPY 100 @ 553 EXP 10/31/2024 puts ($746K).
Portfolio Sells Q2 2024 → Q3 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2024 % Of Portfolio Change To Portfolio ▲ MRK Merck & Co. Inc. Sold out 0.00% −3.64 TMO Thermo Fisher Scientific Inc. Sold out 0.00% −3.46 BIIB Biogen Inc. Sold out 0.00% −3.11 RMD Resmed Inc. Sold out 0.00% −2.56 EW Edwards Lifesciences Corp. Sold out 0.00% −2.47 PODD Insulet Corp. Sold out 0.00% −2.25 A Agilent Technologies Inc. Sold out 0.00% −2.03 DXCM Dexcom Inc. Sold out 0.00% −1.52 NTRA Natera Inc. Sold out 0.00% −1.45 MEDP Medpace Holdings Inc. Sold out 0.00% −1.38 VRTX Vertex Pharmaceuticals Inc. Reduce -33.3% 1.98% −1.16 BRKR Bruker Corp. Sold out 0.00% −1.14 LLY Eli Lilly & Co. Reduce -3.3% 5.48% −0.59 CAH Cardinal Health Inc. Reduce -25.0% 2.12% −0.51 COR Cencora Inc. Reduce -3.9% 2.40% −0.22 BSX Boston Scientific Corp. Reduce -8.7% 3.75% −0.20 SEM Select Medical Holdings Corp. Reduce -3.5% 2.08% −0.19 TEVA Teva Pharmaceutical-SP ADR Reduce -15.0% 1.31% −0.15 HCA HCA Healthcare Inc. Reduce -20.0% 3.47% −0.12 EHC Encompass Health Corp. Reduce -9.1% 2.06% −0.05 MRVI Maravai Lifesciences Hldgs-A Reduce -5.6% 1.51% +0.07 SNN Smith & Nephew PLC -Spon ADR Reduce -6.7% 1.86% +0.20 THC Tenet Healthcare Corp. Reduce -7.1% 4.61% +0.45 SGRY Surgery Partners Inc. Reduce -8.0% 3.16% +0.50
Portfolio Buys Q2 2024 → Q3 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2024 % Of Portfolio Change To Portfolio ▼ XBI SS SPDR S&P Biotech ETF New 12.63% +12.63 ABT Abbott Laboratories New 2.92% +2.92 MDT Medtronic PLC New 2.30% +2.30 RVTY Revvity Inc. New 2.18% +2.18 ZBH Zimmer Biomet Holdings Inc. New 1.84% +1.84 STVN Stevanato Group SPA New 1.19% +1.19 UHS Universal Health Services-B Add +12.5% 4.39% +1.09 BAX Baxter International Inc. Add +50.0% 2.43% +0.93 RGEN Repligen Corp. Add +66.7% 1.59% +0.74 ACHC Acadia Healthcare Co. Inc. Add +43.7% 3.11% +0.70 ASND Ascendis Pharma A/S New 0.64% +0.64 SYK Stryker Corp. Add +8.0% 4.16% +0.36 WST West Pharmaceutical Services Add +30.8% 2.18% +0.26 HUM Humana Inc. Add +33.3% 1.35% +0.10 MCK McKesson Corp. Add +11.1% 4.21% −0.48
Options Activity Q2 2024 → Q3 2024 Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 34 $131.7M XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK Q1 2026 34 $131.7M XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK Q4 2025 41 $204.8M XBI, LLY, THC, MCK, HCA Q3 2025 35 $190.5M XBI, LLY, HCA, THC, DHR Q2 2025 38 $223.6M XBI, THC, HCA, MCK, UHS Q1 2025 29 $182.9M XBI, BSX, THC, HCA, LLY Q4 2024 36 $180.8M XBI, LLY, BSX, MCK, SYK Q3 2024 33 $234.6M XBI, LLY, THC, NVO, UHS Q2 2024 37 $223.9M LLY, NVO, MCK, THC, BSX Q1 2024 46 $275.1M XBI, LLY, NVO, BSX, TMO